Bausch + Lomb

BLCO

Market cap $5.87B

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Executive Vice President and Chief Financial Officer Sam Eldessouky will participate in a fireside chat at the 2025 Citi Global Healthcare Conference on Wednesday, Dec. 3, 2025, at 9:00 a.m. ET. A live webcast, as well as a post-event recording, will be available on the I.

Bausch + Lomb Corporation ( BLCO ) Bausch + Lomb Corporation - Analyst/Investor Day November 13, 2025 8:30 AM EST Company Participants Brenton Saunders - CEO & Chairman of the Board Osama Eldessouky - Executive VP & CFO Yehia Hashad - Executive VP of Research & Development and Chief Medical officer John Ferris - President of Consumer Mayssa Attar Andrew Stewart - President of Global Pharmaceuticals & International Consumer Yang Yang - President of Vision Care Bryan Reed Luc Bonnefoy - President of Surgical Kelly Swaim Cathleen McCabe Eric Donnenfeld Mark Schaeffer Lejla Vajzovic Conference Call Participants William Trattler Lejla Vajzovic Eric Donnenfeld Mark Schaeffer Patrick Wood - Morgan Stanley, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Kevin Joaquin Joanne Wuensch - Citigroup Inc., Research Division Young Li - Jefferies LLC, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Presentation Brenton Saunders CEO & Chairman of the Board So good morning, everyone. Thank you for joining us here.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its one-of-a-kind ONE by ONE Recycling program, created in collaboration with international recycling leader TerraCycle®, has collected a total of 691,180 pounds, or 114,037,136 units, of used contact lens, eye care and lens care materials in the United States – the equivalent of more than 2.2 million baseballs.

Bausch + Lomb Corporation ( BLCO ) Q3 2025 Earnings Call October 29, 2025 8:00 AM EDT Company Participants George Gadkowski Brenton L. Saunders - CEO & Chairman Osama Eldessouky - Executive VP & CFO Yehia Hashad - Executive VP of Research & Development and Chief Medical officer Conference Call Participants Patrick Wood - Morgan Stanley, Research Division Joanne Wuensch - Citigroup Inc., Research Division Young Li - Jefferies LLC, Research Division David Roman - Goldman Sachs Group, Inc., Research Division Lilia-Celine Lozada - JPMorgan Chase & Co, Research Division Pito Chickering - Deutsche Bank AG, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Gary Nachman - Raymond James & Associates, Inc., Research Division Douglas Miehm - RBC Capital Markets, Research Division Thomas Stephan - Stifel, Nicolaus & Company, Incorporated, Research Division Presentation Operator Good morning, and welcome to Bausch + Lomb's Third Quarter 2025 Earnings Call.

While the top- and bottom-line numbers for Bausch + Lomb (BLCO) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Bausch + Lomb (BLCO) came out with quarterly earnings of $0.18 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.17 per share a year ago.

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2025 financial results. “We're delivering on the vision we laid out in 2023, with a base business engine that continues to hum and steady introduction of innovative products across categories,” said Brent Saunders, chairman and CEO, Bausch + Lomb. “Our loaded and differentiated pipeline featuri.

Bausch + Lomb is seen as a potential buyer for the contact-lens unit and the CEO said he would be interested.

Investors looking for stocks in the Medical Services sector might want to consider either Bausch + Lomb (BLCO) or Danaher (DHR). But which of these two stocks offers value investors a better bang for their buck right now?

VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its third-quarter financial results on Wednesday, Oct. 29, 2025. The company will host a conference call and live webcast at 8 a.m. ET to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch + Lomb website prior to the start of the c.